erythrosine has been researched along with Cardiac Failure in 7 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 1 |
| Ding, G | 1 |
| Fang, Q | 1 |
| Guo, J | 1 |
| Yang, L | 2 |
| Wang, P | 1 |
| Fu, SZ | 1 |
| Li, A | 1 |
| Xia, J | 2 |
| Yu, J | 1 |
| Ma, M | 1 |
| Hu, Z | 1 |
| Huang, L | 1 |
| Liu, R | 1 |
| Jiang, C | 1 |
| Li, S | 1 |
| Yu, M | 1 |
| Xu, X | 1 |
| Zhao, Y | 1 |
| Hu, Q | 1 |
| Xing, W | 1 |
| Zhao, Z | 1 |
| Fawzy, MS | 1 |
| Ashour, H | 1 |
| Shafie, AAA | 1 |
| Dahman, NBH | 1 |
| Fares, AM | 1 |
| Antar, S | 1 |
| Elnoby, AS | 1 |
| Fouad, FM | 1 |
| Devine, LD | 1 |
| Gallagher, AM | 1 |
| Briggs, S | 1 |
| Hill, AJ | 1 |
| Stopyra, W | 1 |
| Alacamli, G | 1 |
| Kaderli, ST | 1 |
| Edebali, S | 1 |
| Alacamli, OG | 1 |
| Sul, S | 1 |
| Canbek, TD | 1 |
| Karalezli, A | 1 |
| Stoicescu, EA | 1 |
| Cherecheanu, AP | 1 |
| Bostan, M | 1 |
| Pîrvulescu, R | 1 |
| Tiu, C | 1 |
| Bujor, I | 1 |
| Popa-Cherecheanu, A | 1 |
| Balogun, MM | 1 |
| Fashola, MB | 1 |
| Shi, X | 1 |
| Yu, X | 1 |
| Duan, X | 1 |
| Vandestienne, M | 1 |
| Braik, R | 1 |
| Lavillegrand, JR | 1 |
| Hariri, G | 1 |
| Demailly, Z | 1 |
| Ben Hamouda, N | 1 |
| Tamion, F | 1 |
| Clavier, T | 1 |
| Ait-Oufella, H | 1 |
| Bampidis, V | 1 |
| Azimonti, G | 1 |
| Bastos, ML | 1 |
| Christensen, H | 1 |
| Durjava, M | 1 |
| Kouba, M | 1 |
| López-Alonso, M | 1 |
| López Puente, S | 1 |
| Marcon, F | 1 |
| Mayo, B | 1 |
| Pechová, A | 1 |
| Petkova, M | 1 |
| Ramos, F | 1 |
| Sanz, Y | 1 |
| Villa, RE | 1 |
| Woutersen, R | 1 |
| Brantom, P | 1 |
| Chesson, A | 1 |
| Westendorf, J | 1 |
| Manini, P | 1 |
| Dusemund, B | 1 |
| Bickel Haase, T | 1 |
| Naumann-Gola, S | 1 |
| Ortner, E | 1 |
| Zorn, H | 1 |
| Schweiggert-Weisz, U | 1 |
| Yang, N | 1 |
| Gao, J | 1 |
| Han, Y | 1 |
| Zhang, L | 1 |
| Furusawa, S | 1 |
| Ikeda, M | 1 |
| Ide, T | 1 |
| Kanamura, T | 1 |
| Miyamoto, HD | 1 |
| Abe, K | 1 |
| Ishimaru, K | 1 |
| Watanabe, M | 1 |
| Tsutsui, Y | 1 |
| Miyake, R | 1 |
| Fujita, S | 1 |
| Tohyama, T | 1 |
| Matsushima, S | 1 |
| Baba, Y | 1 |
| Tsutsui, H | 1 |
| Dani, S | 1 |
| Kumar, R | 1 |
| Sharma, H | 1 |
| Choudhary, RJ | 1 |
| Goyal, N | 1 |
| Kaur, P | 1 |
| Pandit, R | 1 |
| Pang, Y | 1 |
| Bjornsson, R | 1 |
| Chung, HR | 1 |
| Miller, JE | 1 |
| Suh, JD | 1 |
| Margolis, G | 1 |
| Hamuda, N | 1 |
| Kobo, O | 1 |
| Elbaz Greener, G | 1 |
| Amir, O | 1 |
| Homoud, M | 1 |
| Madias, C | 1 |
| Heist, EK | 1 |
| Ruskin, JN | 1 |
| Kazatsker, M | 1 |
| Roguin, A | 1 |
| Leshem, E | 1 |
| Rozen, G | 1 |
| Biasibetti, M | 1 |
| Rojas, DB | 1 |
| Hentschke, VS | 1 |
| Moura, DJ | 1 |
| Karsten, M | 1 |
| Wannmacher, CM | 1 |
| Saffi, J | 1 |
| Dal Lago, P | 1 |
| Schillinger, W | 1 |
| Teucher, N | 1 |
| Sossalla, S | 1 |
| Kettlewell, S | 1 |
| Werner, C | 1 |
| Raddatz, D | 1 |
| Elgner, A | 1 |
| Tenderich, G | 1 |
| Pieske, B | 1 |
| Ramadori, G | 1 |
| Schöndube, FA | 1 |
| Kögler, H | 1 |
| Kockskämper, J | 1 |
| Maier, LS | 1 |
| Schwörer, H | 1 |
| Smith, GL | 1 |
| Hasenfuss, G | 1 |
| Steen, M | 1 |
| Reidenberg, MM | 1 |
| Affrime, M | 1 |
| Dietzel, L | 1 |
| Trautvetter, E | 1 |
| von Recum, A | 1 |
| Poirson, JP | 1 |
| Werner, J | 1 |
| Gorbachenkov, AA | 1 |
| Batrachenko, IP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure[NCT00699361] | Phase 3 | 0 participants (Actual) | Interventional | 2008-08-31 | Withdrawn (stopped due to Study withdrawn for financial issues) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for erythrosine and Cardiac Failure
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm | 2022 |
1 trial available for erythrosine and Cardiac Failure
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm | 2022 |
6 other studies available for erythrosine and Cardiac Failure
| Article | Year |
|---|---|
The influence of low-level laser therapy on parameters of oxidative stress and DNA damage on muscle and plasma in rats with heart failure.
Topics: Animals; Antioxidants; DNA Damage; Fluoresceins; Glutathione Peroxidase; Heart Failure; Hemodynamics | 2014 |
Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Actin Cytoskeleton; Aniline Compounds; Animals; Anti-Ulcer | 2007 |
[Mercury poisoning caused by topical treatment of burns with merbromine (mercurochrome)].
Topics: Administration, Topical; Adult; Anuria; Burns; Fluoresceins; Heart Failure; Humans; Male; Merbromin; | 1983 |
Influence of disease on binding of drugs to plasma proteins.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Proteins; Blood Urea Nitrogen; Carbon Radioisotopes; C | 1973 |
[Arm-lip-time in healthy dogs and dogs with heart diseases].
Topics: Animals; Blood Circulation Time; Dog Diseases; Dogs; Female; Fluoresceins; Heart Failure; Male | 1972 |
[Fluorescent angiography of the fundus oculi in patients with chronic circulatory insufficiency].
Topics: Adult; Angiography; Blood Circulation; Blood Flow Velocity; Cardiac Output; Constriction; Dye Diluti | 1971 |